Security key
48115J109
Journey Medical Corp - Common Stock SH (DERM)
CUSIP: 48115J109
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock SH
- Total 13F shares
- 2,495,301
- Total 13F value
- $17,067,859
- Share change
- -404,796
- SEC-reported price per share
- $6.84
- Number of holders
- 3
- Value change
- -$2,768,811
- Number of buys
- 1
- Number of sells
- 4
- Shares outstanding
- 22,265,936
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
3
Top holders
3
DERM full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Journey Medical Corp SEC filings
Journey Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48115J109
Recent filing periods:
Ownership snapshot
Top reported holders of DERM - Journey Medical Corp - Common Stock SH (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WASATCH ADVISORS LP
Disclosed value leader
WASATCH ADVISORS LP
Comparable rows
15/15
Latest evidence
01 Jul 2026
13F
13D/G
3/4/5
Lead comparable stake: 11%
13D/G row: WASATCH ADVISORS LP
Showing 1-6 of 15 holder rows.
Quick read
WASATCH ADVISORS LP leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WASATCH ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
WASATCH ADVISORS LP
11%
TANG CAPITAL MANAGEMENT LLC
8%
VANGUARD CAPITAL MANAGEMENT LLC
3.6%
Lindsay A. Rosenwald MD
1.8%
Justin Adam Smith
1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13F
13D/G
Company
|
11%
from 13D/G
|
$20,241,224
2,858,930 shares
|
— | 30 Jun 2026 |
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
8%
|
$14,020,746
1,854,596 shares
|
$0 | 31 Mar 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
3.6%
|
$5,313,454
774,556 shares
|
-$2,962,416 | 30 Jun 2026 |
| Lindsay A. Rosenwald MD |
3/4/5
Director
|
1.8%
|
$1,864,818
397,616 shares
|
— | 25 Jun 2026 |
| Justin Adam Smith |
3/4/5
Director
|
1%
|
$1,086,288
231,618 shares
|
— | 01 Jul 2026 |
| Miranda Jayne Toledano |
3/4/5
Director
|
0.76%
|
$790,818
168,618 shares
|
— | 01 Jul 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
2,495,301
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q4 2025 Across Filers
Q4 2025 holders
76
Q3 2026 holders
3
Holder diff
-73
| Investor | Q4 2025 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend